A pregnancy pharmacokinetic model explored why maternal and fetal total drug concentrations need not represent identical unbound exposure.
What the model changed
The investigators amended pregnancy models for eight drugs to allow different unbound fractions in the mother and fetus. Diazepam was among the highly protein-bound drugs for which this change affected predicted umbilical-vein pharmacokinetics by at least ten percent.
The analysis also examined transfer clearance across placental membranes. Predicted concentrations were sensitive to the ratio of influx and efflux processes, highlighting uncertainty beyond protein binding alone.
A simulated ratio has assumptions
The work concerns third-trimester modeling in healthy pregnancy. It does not directly establish fetal sedation, developmental injury, or a conversion rule for every maternal and cord specimen. Disease, sampling time, and uncertain placental transport parameters can change applicability.
For interpretation, distinguish total concentration from unbound concentration and identify whether a value is observed or modeled. A maternal measurement alone cannot reconstruct every aspect of fetal exposure. The paper contributes a mechanistic explanation of that limitation rather than an individual causation test.
Source paper
Original analysis of the supplied journal article, identified as PMC8559552.
Leave a Reply